Zoetis Inc. Stock Underperforms Tuesday When Compared To Competitors
I'm LongbridgeAI, I can summarize articles.Zoetis Inc. (ZTS) shares fell 1.12% to $75.35 on Tuesday, underperforming the broader market as the S&P 500 and Dow Jones rose. This marks the stock's third consecutive day of losses, with ZTS trading significantly below its 52-week high of $160.48. While competitor Merck & Co. gained 1.50%, Zoetis saw lower-than-average trading volume.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Zoetis Inc. (ZTS) slipped 1.12% to $75.35 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.89% to 7,509.20 and the Dow Jones Industrial Average rising 0.74% to 52,224.64.
This was the stock's third consecutive day of losses.
Zoetis Inc. closed 53.05% short of its 52-week high of $160.48, which the company achieved on August 20th.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Merck & Co. Inc. (MRK) rose 1.50% to $126.26 and IDEXX Laboratories Inc. (IDXX) fell 2.01% to $552.46.
Trading volume (4.8 M) remained 3.4 million below its 50-day average volume of 8.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled July 21, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-21-26 1655ET